Achieving global access to heart rhythm therapies in the next decade: A tangible goal

Journal of Interventional Cardiac Electrophysiology

Volumn 17, Issue 3, 2006, Pages 163-168

  Saksena, Sanjeev ^a,b,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Electrophysiology Research Foundation   (United States)

^c NONE   (United States)

Author keywords

Cardiac diseases; Global access; Health care policy; Heart rhythm therapies

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; CEREBROVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; ECONOMIC ASPECT; ELECTROPHYSIOLOGY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROMOTION; HEALTH SURVEY; HEART ARRHYTHMIA; HEART PACING; HEART RHYTHM; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MEDICAL TECHNOLOGY; PACEMAKER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL;

ARRHYTHMIA; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; WORLD HEALTH;

EID: 34247216718     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9072-y     Document Type: Review

References (20)

1. Anderson, R. N. (2002). Deaths: Leading causes for 2000. National vital statistics report. Vol. 50, No. 16. National Center for Health Statistics, Public Health Service. Washington, US Government Printing Office, Sept.
2. Hospitalizations in the elderly population, 2003, HCUP statistical brief # 6, p. 6, Table 2: http://www.hcup-us.ahrq.gov/reports/statbriefs.jsp.
3. Reddy, K. S. (2004). Cardiovascular disease in non-Western countries. New England Journal of Medicine, 350(24), 2438.
4. World Health Organization: Europe: Mortality indicators by 67 causes of death, age and sex: http://www.euro.who.int/eprise/main/WHO/InformationSources/ Data/20011017_1.
5. Mond, H., Irwin, M., Morillo, C., & Ector, H. (2004). The world survey of cardiac pacing and cardioverter defibrillators: calendar year. Pacing and Clinical Electrophysiology, 27(7), 955-964, Jul.
6. Frost & Sullivan (2004). Strategic analysis of world cardiac rhythm markets. http://www.medicaldevices.frost.com.
7. Scheinman, M. M., & Huang, S. (2000). The 1998 NASPE prospective catheter ablation registry. Pacing and Clinical Electrophysiology, 23(6), 1020-1028, Jun.
8. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111(9), 1100-1105.
9. Mendis, S., Abegunde, D., Yusuf, S., Ebrahim, S., Shaper, G., Ghannem, H., et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE). Geneva, Switzerland: World Health Organization.
10. Reddy, K. K., Rao, A. P., & Reddy, T. P. (2002). Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pacific Journal of Clinical Nutrition, 11(2), 98-103.
11. HeartBeat International (2004). Annual report. http://www. heartbeatintl.org.
12. Sekscenski, E. S. (2005). Implementation of medicare CAHPS fee for service survey. Final report for the 2004 survey. Centers for medicare & medicaid services, Baltimore, MD. http://www.hhs. gov., December.
13. Editorial (1999). Drugs for AIDS in Africa. New York Times, August 23.
14. Cleland, J., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2006). Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. European Heart Journal, 27(16), 1928-1932, Aug.
15. Tang, A. S., Ross, H., Simpson, C. S., Mitchell, L. B., Dorian, P., Goeree, R., et al. (2005). Canadian cardiovascular society/Canadian heart rhythm society position paper on implantable cardioverter defibrillator use in Canada. Canadian Journal of Cardiology, 21(Suppl A), 11-18, May.
16. Natarajan, M. K., Mehta, S. R., Holder, D. H., Goodhart, D. R., Gafni, A., Shilton, D., et al. (2002). The risks of waiting for cardiac catheterization. Canadian Medical Association Journal, 26, 167(11), 1233-1240.
17. Gupta, D., Natarajan, M. K., Gafni, A., Wang, L., Shilton, D., Holder, D., et al. (2006). Capacity planning for cardiac catheterization: A case study. Health Policy, Sep 9.
18. Mehta, S. R., Cannon, C. P., Fox, K. A., Wallentin, L., Boden, W. E., Spacek, R., et al. (2005). Routine vs. selective invasive strategies in patients with acute coronary syndromes: A collaborative metaanalysis of randomized trials. JAMA, 293(23), 2908-2917, Jun 15.
19. Cooper, R. S., Kennelly, J. F., & Orduñez-Garcia, P. (2006). Health in Cuba. International Journal of Epidemiology, 35, 817-824.
20. Spiegel, J. M. (2006). Daring to learn from a good example and break the 'Cuba taboo'. International Journal of Epidemiology, 35 (4), 825-826, Aug.